CDE Catalog | NINDS Common Data Elements

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

Subdomain Name

CRF Name

Displaying 651 - 675 of 755

Operations

Selected 25 rows in this page.

The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
Select all	CDE ID	CDE Name	Definition	Classification	CRF Name	Copyrighted or trademarked	Disease Name	Subdisease Name
F2059-C20575	C20575	Quality of Life in Neurological Disorders (Neuro-Qol) - Usual activity help requirement fatigue assessment past week scale	The scale representing how often the participant needed help during usual activities because of weakness in the past 7 days, as part of the Quality of Life in Neurological Disorders (Neuro-Qol)	Supplemental	Neuro-QOL Adult Bank - Fatigue	False	General (For all diseases)	General (For all diseases)
F0016-C00030	C00030	Race USA category	The patient's self declared racial origination, independent of ethnic origination, using OMB approved categories	Core	Demographics	0	General (For all diseases)	General (For all diseases)
F1807-C00030	C00030	Race USA category	The patient's self declared racial origination, independent of ethnic origination, using OMB approved categories	Core	General Core	False	General (For all diseases)	General (For all diseases)
F0016-C00033	C00033	Race USA maternal category	Race(s) the participant's mother most closely identifies with	Supplemental	Demographics	0	General (For all diseases)	General (For all diseases)
F0016-C00032	C00032	Race USA paternal category	Race(s) the participant's father most closely identifies with	Supplemental	Demographics	0	General (For all diseases)	General (For all diseases)
F0038-C02214	C02214	Randomized date and time	Date (and time, if applicable and known) the participant/subject is randomly assigned (i.e., by chance not choice) to an intervention/treatment group or control group	Supplemental	Informed Consent and Enrollment	False	General (For all diseases)	General (For all diseases)
F0038-C02213	C02213	Randomized indicator	Indicator of whether the participant/subject was randomly assigned (i.e., by chance not choice) to an intervention/treatment group or control group.	Supplemental	Informed Consent and Enrollment	False	General (For all diseases)	General (For all diseases)
F0026-C01535	C01535	Respiratory rate	Rate of the participant's breathing (inhalation and exhalation)	Supplemental	Vital Signs	False	General (For all diseases)	General (For all diseases)
F0003-C18492	C18492	Screening visit date and time	Date (and time, if applicable and known) the participant/subject was interviewed and screened for potential enrollment into the study	Supplemental	Screening Log	False	General (For all diseases)	General (For all diseases)
F0003-C19069	C19069	Screening visit eligibility other text	The free-text field related to 'Screening visit eligibility status' specifying other text. The status determined from screening criteria that indicates whether a participant/subject may be eligible for a study	Supplemental	Screening Log	False	General (For all diseases)	General (For all diseases)
F0003-C18493	C18493	Screening visit eligibility status	The status determined from screening criteria that indicates whether a participant/subject may be eligible for a study	Supplemental	Screening Log	False	General (For all diseases)	General (For all diseases)
F0003-C19070	C19070	Screening visit ineligibility primary other text	The free-text field related to 'Screening visit ineligibility primary reason' specifying other text. The primary reason identified during a screening visit which makes the potential participant/subject not eligible for a study	Supplemental	Screening Log	False	General (For all diseases)	General (For all diseases)
F0003-C18494	C18494	Screening visit ineligibility primary reason	The primary reason identified during a screening visit which makes the potential participant/subject not eligible for a study	Supplemental	Screening Log	False	General (For all diseases)	General (For all diseases)
F0003-C19071	C19071	Screening visit not enrolled primary other text	The free-text field related to 'Screening visit not enrolled primary reason' specifying other text. The primary reason to indicate why the potential participant/subject is not enrolled in a study during a screening visit	Supplemental	Screening Log	False	General (For all diseases)	General (For all diseases)
F0003-C18496	C18496	Screening visit not enrolled primary reason	The primary reason to indicate why the potential participant/subject is not enrolled in a study during a screening visit	Supplemental	Screening Log	False	General (For all diseases)	General (For all diseases)
F0004-C20405	C20405	Serious adverse event anticipate indicator	Indicator of whether the serious adverse event was anticipated	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C60376	C60376	Serious adverse event associate congenital anomaly birth defect indicator	Indicator of whether the serious adverse event is associated with a congenital anomaly or birth defect	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C60380	C60380	Serious adverse event cause discontinue study indicator	Indicator of whether the serious adverse event caused the participant to be discontinued from the study	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20406	C20406	Serious adverse event comment text	The free-text field to provide any additional information that pertains to the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20396	C20396	Serious adverse event concomitant medication text	The free-text field that describes the concomitant medications taken specific to the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20394	C20394	Serious adverse event end date and time	Date (and time, if applicable and known) on which the serious adverse event discontinued/stopped	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C20399	C20399	Serious adverse event end study intervention indicator	Indicator of whether the study intervention was discontinued due to the serious adverse event	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C02309	C02309	Serious adverse event indicator	Indicator of whether the adverse event is serious	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)
F0009-C02309	C02309	Serious adverse event indicator	Indicator of whether the adverse event is serious	Supplemental	Adverse Events	0	General (For all diseases)	General (For all diseases)
F0004-C60373	C60373	Serious adverse event initial prolong hospital indicator	Indicator of whether the serious adverse event resulted in initial or prolonged hospitalization for the participant	Supplemental	Serious Adverse Events	0	General (For all diseases)	General (For all diseases)

Displaying 651 - 675 of 755

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.